BIBLIGRAFÍA
1. LI E, STANLEY Jr SM. The role of newer antibiotics in Gastroenterology. Gastrointest Clin North Am 21:613629,1992. 2. MORROW JD, NEUZIL KM. Pharmacology of antimicrobial agents used in the therapy of gastrointestinal infections . In : Blaser MJ, Smith PD, Ravdin JL, Greenberg HB y Guerrant RL eds. Infections of the Gastrointestinal Tract. Raven Press., New York 13451384,1995. 3. WEISS ME, ADKINSON NF. B-lactam allergy. In: Mandell GL, Douglas RG, Bennett JE eds. Principles and practice of infections disease, 3rd ed. New York. Churchill Livingstone 264-269, 1990. 4. KAPLAN MS Penicillin Allergy . In Lichtenstein LM , Fauci AS, eds. Current therapy in allergy, immunology and rheurnatology. 4th ed. St. Louis: BC Decker, 126131 1992. 5. LUSK RH, FEKETY FR, SILVA J et al. Gastrointestinal side effects of clindamycin and penicillin therapy . J infect Dis 135(suppl) : 111-119 , 1977. 6. GURWITH MJ , RABIN HR, LOVE K. Cooperative Antibiotic Diarrhea Stydy Group. Diarrhea associated with clindamycin and ampicillin therapy. J Infect Dis 135(Suppl): 104-110, 1977. 7.- WADEJC, PETTYBG, CONRAD GS, etal. Cephalothin plus an aminoglycoside is more nephotoxic than methicillin plus an aminoglycoside . Lancet 2:604606,1978. 8. SMITH CR, LIPSKY JJ, LASKIN OL, HELLMAN DB et al. Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. N Engl J Med 302:1106-1109,1980. 9. SATO K, HOSHINO K , MITSUHASHI Y. Mode of action of new quinolones : The inhibitory activity on DNA gyrese. Prog Drug Res 38: 121-132, 1992. 10.- CHRIST W CEHNERT T, VLBRICH B. Specific toxicologic aspects of the quinolones . Rev Infect Dis 1 O(Suppl) : 141-146,1988. 11.- STEIGBIGEL NH . Erythromycin , lincomycin and clindamycin. In: Mandell GL, Douglas RG, Bennett JE eds. Principles and practice of infections disease ,3rd ed. New York.Churchill Livingstone, 308-317 , 1990. 12.- FINEGOLD SM, MATHISEN GE. Metronidazole.ln : Mandell GL, Douglas RG , Bennett JE eds. Principles and practice of infections disease 3rd ed. New York.Churchill Livingstone. 303-309,1990 13.- GLUPCZNSKI Y, BERETTE A, DEKOSTER E. et al. Metronidazole resistence in Helicobacter pylori Lancet; 335: 539-540, 1990. 14.- STANDIFORD H C. Tetracyclines and chloranfenicol . In : Mandell GL, Douglas FIG , Bennett JE eds. Principles and practice of infections disease 3rd ed. New York. Churchill Livingstone .284-295 1990 15.- CRAVEN GR, GAVIN R, FANNINGBT. The transfer RNA binding site of the 30S ribosome and the site of tetracycline inhibition. Symp quant biol. 34: 129-137 1 1969. 16.- OLEINICK NC. The erythromycins. In: Corcoran JW , Hahn FE, eds. Mechanisms of action of antimicrobial and antitumor agents . New York. Springer-Verlag . 396-416,1975. 17, ITOH Z, SUZUKI T, NAKAYA M , INOUE M et al. Gastrointestinal motor-stimulating activity of macrolide antibiotics and analtsis of their side effects of the canine gut . Antimicrob Agents Chemother .26:863869, 1984. 18.- Safety of terfenadine and astemizole. Med Lett. 34:910,1992. 19, HOPKINS S. Clinical toletation and safety of azithromycin. Am J Med.91(Supp 3A): 4045,1991. 20, PETERS DH , CLISSOLD SP . Clarithromycin :a review of its antimicrobial activity , pharmacokinetic properties and therapeutics potential . Drugs 44:117164,1992. 21, THEN RL. Mechanisms of resistence of trimethoprim, the sulfonamides and trimethoprim-sulfametoxasole .Rev Infect Dis 4:261-269, 1982 . 22,. LAWSON DH, PAICE BJ . Adverse reactions to TMP SMX. Rev Infect Dis. 4:429-433,1982. 23. FEKETY R , SHAH AB . Diagnosis and treatment of Clostridium diff icile . JAMA 269:71-75, 1993 24. GERACI JE. Vancomycin. Mayo Clin Proc 52: 631634, 1977. 25. MEYER GW. Endocarditis prophilaxis for gastrointestinal procedures : A rebuttal for the newest American Heart Association recommendations . Gastrointest Endosc. 37: 201, 1991 26, DEVIERE J, MOTTE MD , DUMONCEAU JM, et al Septisemia after endoscopy retrograde cholangiopancreatography. Endoscopy 22: 72, 1990. 27. JAIN NK, LARSON DE, SCHROEDER KW, et al. Antibiotic prophylaxis of percutaneous endoscopy gastrostomy: A prospective randomized, doubleblind clinical trial . Ann Intern Med . 107:824, 1987 28. FLEISCHER D. Recomendations for antibiotic prophylaxis before endoscopy. Am J Gastroenterology. 84: 1484 , 1989 . 29. DAJANI AS, BISNOAL, CHUNG KJ, etal. Prevention of bacterial endocarditis : Recommendations of the by the American Heart association. JAMA 264: 2919,1990. 30. KEEFFE EB . Antibiotic prophylaxis : Who , when and how. Gastrointest Endosc North Am . 3:431, 1993. 31. BARTLETT JG. Antibiotic-Associated Diarrhea en Blaser MJ, Smith PD, Ravdin J1 , Greenberg HB , y Guerrant RL . New York,Raven Press 1995 . 32. BORRIELLO SP , LARSON HE , WELCHAR. Enterotoxigenic Clostridiurn perfringens : a possible cause of anti bi oti c-assoc iated diarrhoea in elderly patients . Lancet 1: 305,1984. 33. DANNA PL, URBAN D, BELLIN E, RAHALLJJ. Role of candida in pathogenesis of antibiotic-associated diarrhoea in elderly patients. Lancet 337: 511-515, 1991. 34.- COOPER TW . Secretory dierrhea and candidal overgrowth : cause and effect? J Infect Dis 164: 823,1991. 35.- SANCHEZ E, BUSSALLEU A, FINCH R, GILMAN R, et al. Baja incidencia de colitis pseudomembranosa asociada a antibióticos en un Hospital General de Lima. Rev. Esp. Enf. Digest. 77, 2 (120-124), 1990. 36.- BARTLETT JG . Antibiotic-associated diarrhea . Clin Infect Dis 15:573 1992. 37.- TEDESCO FJ , BARTON RW , ALPERS DH. Clinclamycin-associated colitis: A prospective study. Ann Intern Med.81;429,1974. 38.- BARTLETT JG, TAYLOR NW, CHANG TW, DZIN K JA . Clinical and laboratory observations in Clostridiurn diff icile colitis. Am J Clin Nutr 136:876, 1981 . 39.- BARTLETT JG. Clostridium difficile: clinical considerations . Rev Infect. Dis 12: S244, 1990. 40.- SETTLE CD y WILCOX MH . Antibiotic- induced Clostridiurn diff icile infection. Aliment Pharmacol Ther 10:835-841 1996.
|